References
- Sen CK. Wound healing essentials: let there be oxygen. Wound repair and regeneration: official publication of the Wound Healing Society [. And] the European Tissue Repair Society. 2009;17(1):1–18.
- Bloom BR, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science. 1966;153(3731):80–82.
- Bernhagen J, Krohn R, Lue H, et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med. 2007;13(5):587–596.
- Tarnowski M, Grymula K, Liu R, et al. Macrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors and inhibits recruitment of cancer-associated fibroblasts. Mol Cancer Res. 2010;8(10):1328–1343.
- Shi X, Leng L, Wang T, et al. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity. 2006;25(4):595–606.
- Leng L, Metz CN, Fang Y, et al. MIF signal transduction initiated by binding to CD74. The Journal of Experimental Medicine. 2003;197(11):1467–1476.
- Kindt N, Journe F, Laurent G, et al. Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targets. Oncology Letters. 2016;12(4):2247–2253.
- Grieb G, Kim BS, Simons D, et al. MIF and CD74 - suitability as clinical biomarkers. MRMC. 2015;14(14):1125–1131.
- Rosado Jde D, Rodriguez-Sosa M. Macrophage migration inhibitory factor (MIF): a key player in protozoan infections. Int J Biol Sci. 2011;7(9):1239–1256.
- O'Reilly C, Doroudian M, Mawhinney L, et al. Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities. Med Res Rev. 2016;36(3):440–460.
- Simons D, Grieb G, Hristov M, et al. Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment. J Cell Mol Med. 2011;15(3):668–678.
- Grieb G, Piatkowski A, Simons D, et al. Macrophage migration inhibitory factor is a potential inducer of endothelial progenitor cell mobilization after flap operation. Surgery. 2012;151(2):268–277 e1.
- Kim BS, Rongisch R, Hager S, et al. Macrophage Migration Inhibitory Factor in Acute Adipose Tissue Inflammation. PLoS One. 2015;10(9):e0137366.
- Shimizu T, Ohkawara A, Nishihira J, et al. Identification of macrophage migration inhibitory factor (MIF) in human skin and its immmunohistochemical localization. FEBS Letters. 1996;381(3):199–202.
- Gilliver SC, Emmerson E, Bernhagen J, et al. MIF: a key player in cutaneous biology and wound healing. Experimental Dermatology. 2011;20(1):1–6.
- Ashcroft GS, Mills SJ, Lei K, et al. Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. J Clin Invest. 2003;111(9):1309–1318.
- Foltynski P, Ladyzynski P, Ciechanowska A, et al. Wound Area Measurement with Digital Planimetry: Improved Accuracy and Precision with Calibration Based on 2 Rulers. PloS One. 2015;10(8):e0134622.
- Gilliver SC, Emmerson E, Bernhagen J, et al. MIF: a key player in cutaneous biology and wound healing. Exp Dermatol. 2011;20(1):1–6.
- Emmerson E, Campbell L, Ashcroft GS, et al. Unique and synergistic roles for 17beta-estradiol and macrophage migration inhibitory factor during cutaneous wound closure are cell type specific. Endocrinology. 2009;150(6):2749–2757.
- Ansell DM, Campbell L, Thomason HA, et al. A statistical analysis of murine incisional and excisional acute wound models. Wound repair and regeneration: official publication of the Wound Healing Society. Wound Repair Regen. 2014;22(2):281–287.
- Dewor M, Steffens G, Krohn R, et al. Macrophage migration inhibitory factor (MIF) promotes fibroblast migration in scratch-wounded monolayers in vitro. FEBS Letters. 2007;581(24):4734–4742.
- Cassetta L, Cassol E, Poli G. Macrophage polarization in health and disease. TheScientificWorldJournal. 2011;11:2391–2402.
- Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007;117(1):175–184.
- Chesney JA, Mitchell RA. 25 Years On: A Retrospective on Migration Inhibitory Factor in Tumor Angiogenesis. Mol Med. 2015;21(S1):S19–S24.
- Wang X, Chen T, Leng L, et al. MIF produced by bone marrow-derived macrophages contributes to teratoma progression after embryonic stem cell transplantation. Cancer Research. 2012;72(11):2867–2878.
- White ES, Strom SR, Wys NL, et al. Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity. J Immunol. 2001;166(12):7549–7555.
- Sauler M, Zhang Y, Min JN, et al. Endothelial CD74 mediates macrophage migration inhibitory factor protection in hyperoxic lung injury. Faseb J. 2015;29(5):1940–1949.
- Hillgruber C, Steingraber AK, Poppelmann B, et al. Blocking von Willebrand factor for treatment of cutaneous inflammation. J Invest Dermatol. 2014;134(1):77–86.
- Oda S, Oda T, Nishi K, et al. Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner. PloS One. 2008;3(5):e2215.
- Xu X, Wang B, Ye C, et al. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer. Cancer Letters. 2008;261(2):147–157.
- Kok T, Wasiel AA, Cool RH, et al. Small-molecule inhibitors of macrophage migration inhibitory factor (MIF) as an emerging class of therapeutics for immune disorders. Drug Discovery Today. 2018;23(11):1910–1918.